OrbiMed’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,935,200
Closed -$18.7M 179
2020
Q4
$18.7M Hold
1,935,200
0.16% 104
2020
Q3
$17.4M Hold
1,935,200
0.22% 91
2020
Q2
$23.9M Buy
+1,935,200
New +$21.9M 0.34% 70
2019
Q2
Sell
-4,079,000
Closed -$64M 135
2019
Q1
$64M Buy
+4,079,000
New +$71.9M 0.99% 32
2017
Q4
Sell
-405,500
Closed -$7.14M 143
2017
Q3
$7.14M Sell
405,500
-120,800
-23% -$2.72M 0.07% 115
2017
Q2
$17.5M Buy
526,300
+113,700
+28% +$3.52M 0.18% 84
2017
Q1
$13.2M Sell
412,600
-201,900
-33% -$6.89M 0.15% 87
2016
Q4
$22.3M Sell
614,500
-1,216,900
-66% -$48.6M 0.28% 66
2016
Q3
$84.3M Sell
1,831,400
-928,400
-34% -$48.4M 0.96% 40
2016
Q2
$139M Buy
2,759,800
+63,800
+2% +$3.4M 1.45% 22
2016
Q1
$144M Buy
2,696,000
+250,000
+10% +$14.7M 1.52% 21
2015
Q4
$161M Buy
2,446,000
+247,000
+11% +$15.3M 1.45% 23
2015
Q3
$124M Buy
2,199,000
+1,892,000
+616% +$123M 1.25% 25
2015
Q2
$18.1M Sell
307,000
-784,000
-72% -$48.4M 0.15% 87
2015
Q1
$68M Buy
1,091,000
+691,000
+173% +$40.2M 0.58% 48
2014
Q4
$23M Sell
400,000
-262,000
-40% -$14.6M 0.22% 71
2014
Q3
$35.6M Buy
+662,000
New +$35.1M 0.37% 53

Other funds holding TEVA